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Abstract
Background: The rapid growth of the nanotechnology industry and the wide application of various nanomaterials 
have raised concerns over their impact on the environment and human health. Yet little is known about the 
mechanism of cellular uptake and cytotoxicity of nanoparticles. An array of nanomaterials has recently been 
introduced into cancer research promising for remarkable improvements in diagnosis and treatment of the disease. 
Among them, quantum dots (QDs) distinguish themselves in offering many intrinsic photophysical properties that are 
desirable for targeted imaging and drug delivery.
Results: We explored the kinetics and mechanism of cellular uptake of QDs with different surface coatings in two 
human mammary cells. Using fluorescence microscopy and laser scanning cytometry (LSC), we found that both MCF-7 
and MCF-10A cells internalized large amount of QD655-COOH, but the percentage of endocytosing cells is slightly 
higher in MCF-7 cell line than in MCF-10A cell line. Live cell fluorescent imaging showed that QD cellular uptake 
increases with time over 40 h of incubation. Staining cells with dyes specific to various intracellular organelles indicated 
that QDs were localized in lysosomes. Transmission electron microscopy (TEM) images suggested a potential pathway 
for QD cellular uptake mechanism involving three major stages: endocytosis, sequestration in early endosomes, and 
translocation to later endosomes or lysosomes. No cytotoxicity was observed in cells incubated with 0.8 nM of QDs for 
a period of 72 h.
Conclusions: The findings presented here provide information on the mechanism of QD endocytosis that could be 
exploited to reduce non-specific targeting, thereby improving specific targeting of QDs in cancer diagnosis and 
treatment applications. These findings are also important in understanding the cytotoxicity of nanomaterials and in 
emphasizing the importance of strict environmental control of nanoparticles.
Background
The arsenal of nanomaterials keeps expanding over the
years as a result of the rapid growth of the nanotechnol-
ogy industry. Nanomaterials are currently being used in a
number of applications, including textiles, cleaning prod-
ucts, sport equipments, biomedicine, and cosmetics [1].
While the potential benefits of nanotechnology have
been widely reported, little is known about the potential
toxicity of nanomaterials [2]. The increasing use of nano-
particles in consumer products and medical applications
underlies the importance of understanding any toxic
effects to humans and the environment that have raised
concerns over the years.
Among various nanomaterials, quantum dots (QDs)
distinguish themselves in their far-reaching possibilities
in many avenues of biomedicine. QDs are nanometer-
sized fluorescent semiconductor crystals with unique
photochemical and photophysical properties. Their
much greater brightness, rock-solid photostability and
unique capabilities for multiplexing, combined with their
intrinsic symmetric and narrow emission bands, have
made them far better substitutes for organic dyes in exist-
ing diagnostic assays [3]. These properties, combined
with the development of ways to solubilize QDs in solu-
tion and to conjugate them with biological molecules,
have led to an explosive growth in their biomedical appli-
cations [4]. Bioconjugated QD fluorescent probes offer a
promising and powerful imaging tool for cancer detec-
tion, diagnosis and treatment. Following the two seminal
papers published on Science in 1998 demonstrating the
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feasibility of using QDs in biological environments [5,6],
many new techniques have been developed during the
last decade, utilizing the unique photophysical properties
of QDs, for in vitro biomolecular profiling of cancer bio-
markers, in vivo tumor imaging, and dual-functionality
tumor-targeted imaging and drug delivery [7].
Early detection of cancer and targeted drug delivery
remain the primary challenges to the cancer research
community. In many cases, the malignancy of tumors is
detected only at advanced stages when high dose of che-
motherapeutic drugs are needed, which raises the cost of
the therapy as well as the risk of side-effects. To mitigate
this problem, early detection of tumors at their incipient
stage and targeted drug delivery system 'pinpointing' can-
cer cells at the tumor site is the key. A tumor-targeting
drug delivery system generally consists of a tumor-recog-
nition moiety and a drug-loaded vesicle. Currently, most
drugs are designed to bind to specific receptors. How-
ever, these drugs lack selectivity for specific sites in the
human body, i.e., specific cells, tissues or organs, since the
receptors may be expressed at various sites of the body.
Nanoparticles for site-specific drug delivery represent a
promising solution to this problem. Mediated by a target-
ing sequence, drug-laden nanoparticles should deliver
their payload only to specific target cells, tissues or
organs under ideal circumstances [8]. A premise of nano-
medicine is that it may be feasible to develop multifunc-
tional constructs combining diagnostic and therapeutic
capabilities, thus leading to better targeting of drugs to
diseased cells. The large surface area combined with ver-
satile surface chemistry makes QDs convenient scaffolds
to accommodate anticancer drugs either through chemi-
cal linkage or by simple physical immobilization, leading
to the development of nanostructures with integrated
imaging and therapy functionalities [7]. Such a system is
capable of targeting drug delivery and imaging the deliv-
ery process simultaneously to monitor the time course of
subcellular location. Several studies have appeared
recently highlighting this application [9-12].
In such applications as cancer diagnosis and drug deliv-
ery, specific uptake of QDs by cancer cells is desired while
non-specific uptake by any cell type should be avoided.
Otherwise, specific targeting of cancer cells cannot be
achieved, as every cell, even the healthy ones, would be
targeted. In this regard, understanding the mechanism of
QD cellular uptake and factors affecting the process is
essential to minimize unwanted non-specific cellular
uptake of QDs. Unfortunately, the endocytic mechanism
of non-targeting QDs (i.e., not bearing special functional-
ization targeting specific component of the cell) has been
poorly studied and remains largely unknown, with only a
few studies appeared recently to addressed this question
[13-15]. In the present study, we used fluorescence
microscopy, laser scanning cytometry (LSC), live cell flu-
orescent imaging and transmission electron microscopy
(TEM) to explore the kinetics and mechanism of cellular
uptake of QDs with different surface coatings by two dif-
ferent cell types representing normal and cancerous cells.
In addition, the localization of QDs in the cytoplasm was
examined with specific organelle markers. The findings
presented here provide information on the mechanism of
QD endocytosis that could be exploited to reduce non-
specific targeting, thereby improving specific targeting of
QDs in cancer diagnosis and treatment applications.
These findings are also important in understanding the
cytotoxicity of nanomaterials in general and in emphasiz-
ing the importance of strict environmental control of
nanoparticles.
Methods
Quantum dots
QDs with emission maxima at 655 nm (QD655) were
obtained from Invitrogen (Carlsbad, CA). These QDs
have a CdSe core and a ZnS shell with three different sur-
face coatings: carboxylic acids (COOH), amine-deriva-
tized PEG, or PEG only, which were sold under the names
Qdot 655 ITK carboxyl (Cat. No. Q21321MP), Qdot 655
ITK amino (PEG) (Cat. No. Q21521MP), and Qtracker
655 non-targeted (Cat. No. Q21021MP) quantum dots,
respectively. At physiological pH, the surface charges on
these coatings are negative, positive, or neutral, respec-
tively.
Cell culture
Human mammary non-tumorigenic epithelial cell line
MCF-10A and human mammary adenocarcinoma epi-
thelial cell line MCF-7 were obtained from ATCC
(Manassas, VA) and cultured under conditions as recom-
mended by the supplier.
QDs cellular uptake
Cells were grown on tissue culture chamber slides (Nunc,
Rochester, NY) to a density of 30,000 cells/cm2, and then
incubated with QD655-COOH, QD655-amine PEG and
QD655-PEG at 37°C for 12 h at final concentrations of
0.8, 0.5, and 0.8 nM respectively. Afterwards, cells were
washed 3 times with PBS and then fixed in 10% neutral-
buffered zinc formalin (Fisher, Pittsburgh, PA) for 45 min.
Afterwards, the cells were counterstained with 4',6-
diamidino-2-phenylindole-2 (DAPI) from Vector Labora-
tories (Burlingame, CA) and viewed directly under fluo-
rescence microscopy or analyzed by laser scanning
cytometry (see next section) as described previously [16-
18].
Laser scanning cytometry (LSC)
Samples were analyzed on a LSC2 laser scanning cytome-
ter of Compucyte Corporation (Cambridge, MA)Xiao et al. Journal of Nanobiotechnology 2010, 8:13
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equipped with 405, 488, and 594 nm lasers and four PMT
detectors. QD655 was excited with a violet laser diode
(405 nm, 15 mW) and detected through 660/20 bandpass
filters respectively. DAPI was excited with the violet laser
diode (405 nm, 15 mW) and detected through a 461/50
nm bandpass filter. Samples were scanned in 0.5 μm steps
and saved both as cytometric data and as PMT-recon-
structed images. Data was acquired and analyzed using
WinCyte software version 3.7.1 (Compucyte).
Kinetic study of QD uptake using live cell microscopy
Fluorescent and Phase images of viable cells were
acquired on an Axiovert 200 Cell Observer inverted
microscope system from Zeiss (Oberkochen, Germany)
t h a t  i n c l u d e d  a n  i n c u b a t i o n  e n c l o s u r e  a r o u n d  o n  t h e
microscope stage. This system maintained normal cell
culture conditions (37°C, 5% CO2 atmosphere, 100% rela-
tive humidity) and allowed multiple regions of interest to
be imaged regularly (every 20 min in this study) through-
out the duration of the experiment. Fluorescence from
QD655 was detected through a 655/40 nm bandpass fil-
ter. Fluorescence images were processed digitally to cor-
rect for spatially uneven fluorescence excitation and for
background fluorescence from QDs that remained sus-
pended in the media solutions. Uneven fluorescence exci-
tation was corrected by normalizing all images by a flat
field image [19]. The flat field image was generated by
imaging a spatially homogeneous 475 nm long pass glass
filter. Correction for background fluorescence was simple
background intensity subtraction where the fluorescence
intensity attributed to background was determined from
cell-free areas (as determined by phase contrast images)
within each region of interest. The background fluores-
cence varied during the experiment, so the background
fluorescence intensity was determined at each time point.
The total intensity over the whole image was then
summed to yield a measurement of the relative accumu-
lation of QDs by cells within the region of interest.
Intracellular localization of QDs
Cells grown on tissue culture chamber slides were treated
with 0.8 nM QD655-COOH for 12 h. The culture
medium was then removed and replaced with medium
pre-warmed to 37°C containing dyes (final concentration
200 nM) for probing intracellular organelles including
ER-Tracker Blue/White DPX for labeling endoplasmic
reticulum (ER), MitoTracker Green for mitochondria,
and LysoTracker Yellow for lysosomes, all obtained from
Invitrogen. Cells were incubated with the dyes for 30 min,
then replaced with fresh medium, followed by fixation
and counterstaining with DAPI as described previously.
Finally, the cells were observed under fluorescence
microscope fitted with the correct filter set. Images were
recorded separately in each fluorescence channel and
merged afterwards.
Transmission electron microscopy (TEM)
Cells were grown to confluence in culture flasks and
treated with 0.8 nM QD655-COOH for 12 h at 37°C.
Cells were then scraped into a centrifuge tube, washed 3
times with phosphate buffered saline (PBS), and fixed in a
2% glutaraldehyde solution diluted in 0.12 M Millonig's
phosphate buffer (pH = 7.3). Whole mounts of primary
fixed samples were washed in DI water, post-fixed with
osmium tetroxide, dehydrated in sequential ethanol solu-
tions, embedded in resin and finally ultramicrotombed.
TEM images were obtained at 100 kV on a Zeiss EM10
CA electron microscope.
Cytotoxicity assay
Cytotoxicity was measured by the MTS assay [20] using
the CellTiter 96 Aqueous One Solution Cell Proliferation
Assay kit from Promega (Madison, WI). Instructions
from the manufacturer were followed. Briefly, cells were
seeded in a 96-well plate at 1 × 104 cells/well and allowed
to adhere overnight at 37°C with 5% CO2. Then cells were
treated with QDs as described above and incubated for
another 72 h. Afterwards the medium containing QDs
was replaced with 100 μl fresh medium and 20 μl of assay
reagent was added to each well. Cells were further cul-
tured for 3 h and the resultant absorbance was recorded
at 490 nm using a 96-well plate reader. Each experiment
was performed with 3 independent replicates and
repeated three times.
Results
Cellular uptake of QDs with different coatings
Human mammary non-tumorigenic MCF-10A cells and
carcinoma MCF-7 cells were incubated with QD655 of
different coatings: carboxylic acid (COOH), amine-
derivatized PEG or PEG only. No detectable intracellular
uptake was observed for either amine-PEG or PEG
coated QDs over 12 h incubation period (data not
shown). However, both cell types internalized large
amount of QD655-COOH after 12 h incubation (Figure
1). The internalized QDs formed large agglomerates
localized around the periphery of the nuclei. It was
observed that the percentage of cells taking up QDs is
slightly higher in the cancerous MCF-7 cells than in the
non-tumorigenic MCF-10A cells.
Quantitation of QD uptake by laser scanning cytometry 
(LSC)
To quantitate QD uptake by MCF-10A and MCF-7 cells,
we performed identical experiments using QD655-
COOH and evaluated the results by laser-scanningXiao et al. Journal of Nanobiotechnology 2010, 8:13
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cytometry. Representative PMT-reconstructed images
are shown in Figure 2. Similar to Figure 1, high levels of
Q D  f l u o r e s c e n c e  w e r e  d e t e c t e d  i n s i d e  t h e  Q D - t r e a t e d
cells for both cell types. The cytometric data for periph-
eral QD655 fluorescence intensity (with spatial exclusion
of the nucleus by DAPI contouring) are shown in the left
panel of the figure with the average fluorescence intensi-
ties indicated. The normalized average fluorescence
intensity (average fluorescence intensity of QD-treated
cells subtracted by that of the untreated cells) for MCF-7
cells (1,553,425.29) was ~2.3-fold as high as that for
MCF-10A cells (687595.65). This result is concordant
with the finding that higher percentage of MCF-7 cells
internalized QD655-COOH than MCF-10A cells.
Kinetic study of QD uptake
The kinetics of QD655-COOH uptake by MCF-7 cells
was studied using a live cell microscopy. Images were
taken every 20 min during 40 h of incubation (Figure 3).
QD fluorescence inside the cells became visible after ~1 h
of incubation and increased almost linearly with time.
The whole process can be visualized in a video clip pro-
vided as Additional file 1.
Intracellular localization of QDs
To find out the intracellular localization of the internal-
ized QDs, MCF-7 cells were treated with QD655-COOH
for 12 h then incubated with dyes for probing intracellu-
lar organelles including ER, mitochondria, and lyso-
s o m e s .  F l u o r e s c e n c e  m i c r o s c o p e  i m a g e s  s h o w e d  t h a t
QDs colocalized with lysosomes (Figure 4) but not with
ER or mitochondria (data not shown). This suggests that
QDs were finally localized within the lysosomes.
QD cellular uptake and intracellular translocation process
To shed light on the internalization of QDs by cells and
their intracellular translocation process, MCF-7 cells
were incubated with QD655-COOH and various stages of
QD intracellular translocation were snapshot using TEM
(Figure 5). QDs attached to the cell surface were engulfed
through the formation of flask-shaped invaginations on
the plasma membrane (Figure 5a). After pinching off the
cell membrane, QDs were sequestered in the endocytic
vesicles or early endosomes (Figure 5b), which slowly
acidified and turned into late endosomes and lysosomes
(Figure 5c). It is worth to note that QDs were dispersed in
early endosomes (near neutral pH) but more densely
packed in late endosomes/lysosomes, presumably due to
the acidic pH therein.
QD cytotoxicity on MCF-7 and MCF-10A cells
MCF-7 and MCF-10A cells were incubated with 0.8 nM
QD655-COOH for 72 h and cell viability was examined
by the MTS assay. No detectable decrease in cell viability
was observed for both cell types (data not shown). Micro-
s c o p i c  o b s e r v a t i o n s  r e v e a l e d  t h a t  b o t h  c e l l s  a p p e a r e d
healthy after QD treatments without noticeable morpho-
logical changes.
Discussion
In summary, the results presented here suggest a poten-
tial pathway for QD cellular uptake mechanism, as illus-
trated in Figure 6, which comprises of three major stages:
(1) endocytosis; (2) sequestering in early endosomes; (3)
translocation to later endosomes or lysosomes (Figure 6).
Endocytosis of nanoparticles by cells may occur
through two major mechanisms named phagocytosis and
pinocytosis [21]. Phagocytosis is the uptake of large parti-
cles by only some specialized mammalian cells such as
macrophages, monocytes, and neutrophils. Pinocytosis is
for the uptake of small particles, solutes and fluid, and
can be found in any cell type. Pinocytosis can be further
classified into four subcategories: macropinocytosis,
clathrin-mediated endocytosis, caveolae-mediated endo-
cytosis, and clathrin/caveolae-independent endocytosis.
Macropinocytosis, through cell surface ruffling, repre-
sents an efficient way for non-selective cellular uptake of
large solute macromolecules with sizes >1 μm; while the
other three, collectively called micropinocytosis, is pre-
ferred for the uptake of smaller particles through the for-
mation of endocytic vesicles of different sizes - clathrin
(~120 nm), caveolae (~60 nm) and clathrin/caveolae-
independent (~90 nm) (see [22] for a detailed review).
Based on the size of the QD655-COOH used in this study
(hydrodynamic diameter 20-30 nm [15]), it is very likely
that QD endocytosis by breast epithelial cells is mediated
through micropinocytosis rather than macropinocytosis.
It has been shown that macropinocytosis is not involved
Figure 1 Cellular uptake of QDs in human mammary non-tumori-
genic MCF-10A cells and carcinoma MCF-7 cells. The QD-treated 
cells were incubated with 0.8 nM QD655 coated with carboxylic acid 
(COOH) for 12 h at 37°C. Blue color represents DAPI-counterstained nu-
cleus, while red color was fluorescence emitted from QD655. The 
white bar represents 20 μm.Xiao et al. Journal of Nanobiotechnology 2010, 8:13
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Figure 2 Laser-scanning cytometry experiments quantitating QD uptake by MCF-10A and MCF-7 cells. Representative PMT-reconstructed im-
ages are shown on the left panel. The cytometric data for peripheral fluorescence intensity (with spatial exclusion of the nucleus by DAPI contouring) 
collected from a channel optimized for QD655 (designated as Long Red 2) are shown on the right panel, with the average fluorescence intensity in-
dicated at the top-right corner.
MCF-10A Cells
Untreated
MCF-10A Cells
QD-treated
MCF-7 Cells
Untreated
MCF-7 Cells
QD-treated
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in QD uptake pathways in human epidermal keratino-
cytes (HEKs) [15].
Clathrin-mediated endocytosis is the most important
mechanism for receptor-mediated uptake, occurs consti-
tutively in all mammalian cells, and plays important phys-
iological roles by carrying out the continuous uptake of
essential nutrients such as the cholesterol-laden low-den-
sity lipoprotein (LDL) [23]. The endocytosis is mediated
through the formation of clathrin-coated pits that are of
100-200 nm in size [24]. Several types of nanoparticles
have been shown to enter cells through clathrin-mediated
pinocytosis, such as FITC-labeled SPION and PEG-PLA
[25,26]. Caveolae are flask-shaped plasma membrane
invaginations of 50-80 nm size rich in cholesterol and
sphingolipids, with shape and structural organization
conferred by caveolin [27]. Caveolae-mediated endocyto-
sis is most notably found in endothelial cells, smooth
muscle cells and adipocytes. The physiological role of
caveolae-mediated endocytosis may include cholesterol
uptake, solute transport and tumor suppression [22,28].
Zhang and Monteiro-Riviere [15] reported that QD655-
COOH internalization by HEK cells was via caveolae/
lipid raft-mediated endocytosis involving LDL receptors
(LDLRs) and scavenger receptors (SRs). This result is
somewhat confusing and need to be further confirmed, as
LDLRs are mainly associated with clathrin-mediated
endocytosis [23]. In addition, SV40 virus entering cells
via caveolae do not fuse with lysosomes after endocytosis
[29]; however, QDs were localized in lysosomes in HEKs
[15] and in mammary epithelial cells as shown in the cur-
rent study. Based on these results, we hypothesize that
QD655-COOH uptake by breast epithelial cells is most
likely through clathrin-mediated endocytosis. Clathrin/
caveolin-independent endocytosis has only been
described in a few examples, e.g., for the recovery of
Figure 3 Kinetics of QD655-COOH uptake by MCF-7 cells. Images 
were taken every 20 min during 40 h of incubation using a live cell mi-
croscopy. a. Representative microscopic flat field images at specific 
time-points indicated. b. Three-dimensional graphs showing intracel-
lular fluorescence intensity of the imaged area at 1 h and 40 h of incu-
bation. The fluorescence intensity was corrected by subtracting 
background fluorescence as determined from cell-free areas of the re-
gion of interest. c. Plot of intracellular fluorescence intensity of the re-
gion of interest over time. Blue dots are fluorescence intensity at each 
timepoint; the straight line is linear regression.
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Figure 4 Colocalization of QDs with lysosomes. MCF-7 cells were 
treated with QD655-COOH for 12 h then incubated with LysoTracker 
Yellow for specific staining of lysosomes. Fluorescence from each 
channel was recorded and merged. The orange color seen in the 
stained cells resulted from the merging of the red fluorescence from 
QDs and the yellow color of the LysoTracker dye. The white bars repre-
sent 20 μm
Control
cells
Stained
cells
DAPI
(blue)
LysoTracker
(Yellow)
QD
(red)
Merged
(mixed)
Figure 5 TEM images illustrating the process of QD cellular up-
take and intracellular translocation. a. QD endocytosis through 
plasma membrane invagination. Black arrows point to QDs attached to 
the cell surface; the white arrow denotes the membrane pit engulfing 
QDs. b. QDs sequestered and dispersed in early endosomes (white ar-
row). c. QDs condensed in late endosomes/lysosomes (white arrow).
abcXiao et al. Journal of Nanobiotechnology 2010, 8:13
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membrane proteins in neurons or the internalization of
the interleukin-2 (IL-2) receptor on lymphocytes [22].
The exact mechanism involved in cellular uptake of QDs
may depend on many factors, such as the size and surface
coating/charge of QDs, the type of cells, etc., more exten-
sive studies are therefore needed to clarify this point.
In stark contrast to the rapid and large intracellular
u p t a k e  o f  Q D 6 5 5 - C O O H ,  n o  d e t e c t a b l e  u p t a k e  w a s
observed for either amine-PEG or PEG coated QDs. Sim-
ilar findings have been reported for QD cellular uptake by
HEK cells [15] and by murine macrophages [30]. The rea-
son for this conspicuous difference is unknown, but most
probably has to do with surface charge on the QDs. At
physiological pH, the surface charge on QD655-COOH is
negative, but is positive or neutral on amine-PEG or PEG
coated QDs, respectively. The impact of surface charge
on cellular uptake of non-targeted QDs has been studied
sporadically and the results have been so far controver-
sial; some studies reported negatively charged QDs can
be internalized by cells [30-32], while others reported
positively charged QDs can be endocytosed [33], still
other studies showed surface coating/charge has no effect
on QD endocytosis [34]. The exact mechanism is
unknown, and may be cell type specific. However, it is
very likely that the endocytosis involved in the internal-
ization of QD655-COOH by the MCF-10A or MCF-7
cells was mediated by receptors that are specific or pref-
erential to anionic ligands. Receptors favoring cationic
ligands such as cell surface proteoglycans had been
reported [35]. It has been suggested that LDLR/SR was
involved in the internalization of QD655-COOH by HEK
cells [15], since the size/charge of LDL or acetylated LDL
(AcLDL), which are recognized by these receptors, are
very similar to those of QD655-COOH.
However, other possible reasons for the preferential
uptake of QD655-COOH could not be excluded. The
QD655-COOH has an amphiphilic surface coating, while
the other two QD types contain a PEG-based outer coat-
ing on top of the amphiphilic inner coating [36]. Thus,
the surface of QD655-COOH could be more hydropho-
bic than that of QDs coated with amine-PEG or PEG. The
higher hydrophobicity for QD655-COOH may facilitate
the transport of the QDs through the cell membrane.
However, further studies are needed to clarify the mecha-
nisms for the differential cellular uptake of the QDs.
The observed condensation of QDs upon translocation
from early endosomes to late endosomes/lysosomes was
probably a result of the pH change in these endocytic
compartments. The pH value in early endosomes is 5.9-
6.0 [37] therefore the QD655-COOH particles are nega-
tively charged and expels one another and stay dispersed.
In lysosomes, the pH drops to 5.0-5.5 [34] and in some
cases can be as low as 4 [37,38], at which the carboxyl
groups on the QD surface strongly protonate and become
practically neutral, thus resulting in QD aggregation. The
protonation of QD surface may result in an increase of
intraendosomal pH and a charge gradient provoking a
water influx and endosomal swelling and disintegration,
resulting in the escape of QDs from the endo-lysosomal
compartment [13]. This phenomenon could be utilized to
target drug-laden QDs to the cytoplasm [39].
MCF-7 is a mammary carcinoma cell line while MCF-
10A is a non-tumorigenic cell line. Both cell types inter-
nalized large amount of QD655-COOH, although the
percentage of endocytosing cells is slightly higher in
MCF-7 cells than in MCF-10A cells. This result implies
that both normal and cancerous cells are able to passively
internalize significant amount of QDs without conjuga-
tion with specific targeting moieties. Therefore, targeting
QDs specifically to cancer cells would not be achievable
unless passive QD delivery is blocked or minimized. A
well known solution is to mask the surface of QDs with
PEG, which can significantly reduce non-specific cellular
uptake of nanoparticles [40]. It has been shown that sur-
face modification with PEG remarkably reduced non-
specific QD uptake by many cell types [41,42]. The results
presented in this study that QDs coated with PEG or
amine-derivatized PEG were not internalized by the cells
add further evidence to the effectiveness of this method.
An importance inference from these results is that future
applications for specific targeting of cancer cells should
use QDs coated with PEG or PEG derivatives.
One major obstacle to clinical applications of QDs is
the concern over their possible cytotoxicity [7]. Cd2+ ions
can be released through oxidative degradation of QDs,
Figure 6 Postulated QD cellular uptake pathway. The process 
comprises of three major stages: (1) endocytosis; (2) sequestering in 
early endosomes (EE); (3) translocation to later endosomes (LE) or lyso-
somes (LS).
(1)
(2)
(3)
Nucleus
EE
LE
LS
(3)Xiao et al. Journal of Nanobiotechnology 2010, 8:13
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and then bind to thiol groups on intracellular proteins.
Also, QDs may aggregate, precipitate on cells, non-spe-
cifically adsorb to biomolecules, and catalyze the forma-
t i o n  o f  r e a c t i v e  o x y g e n  s p e c i e s  ( R O S ) ,  a l l  o f  w h i c h
contribute to QD toxicity. In addition, little is known
about the degradation, metabolism and body clearance of
QDs. The unique structure of QDs presents a complex set
of physic-chemical parameters that confounds systematic
studies on toxicity mechanisms of QDs, such as composi-
tion, size, surface coating, and bioconjugation, etc. Like
most studies in the past, the toxicity study reported here
is primarily observational in nature. Although the results
indicated that no cytotoxic effects of QDs were observed
over an incubation period of 72 h, the large amount of
QDs accumulated inside the cell and their persistence in
the lysosomes underscore the need for long-term studies
of QD toxicity and fate in cells and clearly emphasizes the
importance of strict environmental control of QDs and
other nanoparticles as well.
Conclusions
Surface coating has a profound impact on the cellular
uptake of QDs. PEG modification essentially blocked
non-specific QD delivery into the cells. On the other
hand, QDs coated with COOH were internalized quickly
and with large amount by both cancerous and non-can-
cerous cells. QD cellular uptake involves three major
stages including endocytosis, sequestration in early endo-
somes, and translocation to later endosomes or lyso-
somes. The endocytosis was probably assisted by
receptors specific to ligands with negative charges. These
findings could be exploited to reduce non-specific target-
ing, thereby improving specific targeting of QDs in can-
cer diagnosis and treatment applications. The findings
are also important in understanding the cytotoxicity of
QDs and other nanomaterials in general and in empha-
sizing the importance of strict environmental control of
nanoparticles.
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